TY - JOUR
T1 - Vitamin D Status and Associations in Newborn Formula-Fed Infants during Initial Hospitalization
AU - Hanson, Corrine
AU - Armas, Laura
AU - Lyden, Elizabeth
AU - Anderson-Berry, Ann
N1 - Funding Information:
FUNDING/SUPPORT: This study was supported by a Research Support fund grant from the Nebraska Medical Center and the University of Nebraska Medical Center, and the Department of Pediatrics, University of Nebraska Medical Center, Omaha.
PY - 2011/12
Y1 - 2011/12
N2 - Background: Evidence suggests that adequate vitamin D status in infancy plays a role in improving bone health and preventing disease, including type 1 diabetes, infections, and asthma. The objective of this study was to provide newborn hospitalized infants with American Academy of Pediatrics recommendations of 400 IU/day vitamin D-3 and measure the effect on serum 25(OH)D levels. Design: This trial was conducted August 2009 to June 2010. Infants were randomized to a control were measured from cord blood, every 7 days, and at discharge. Intact parathyroid hormone was measured at discharge. Participants/setting: Fifty-two infants <32 weeks gestational age who received formula feedings during their neonatal intensive care unit hospitalization. Statistical analysis: Patient characteristics for each treatment group were summarized using descriptive statistics. The Mann-Whitney test was used to compare continuous variables, and categorical variables were compared using the χ 2 test or Fisher's exact test. The Pearson correlation coefficient was used to look at associations between continuous variables. Results: The mean cord blood level for all participants was 17.6±7.0 ng/mL. White infants had significantly higher 25(OH)D levels than non-white infants (P=0.0003). The mean 25(OH)D level at discharge of the supplemented group was 23.1±7.0 ng/mL (57.66±17.47 nmol/L), the mean 25(OH)D level of the unsupplemented group was 17.8±4.7 ng/mL (44.43±11.3 nmol/L), (P=0.007). Serum 25(OH)D showed a positive correlation with serum calcium in the first week of life (r=0.44, P=0.003) and negative correlation with parathyroid hormone levels at discharge (r=-0.35, P=0.02). Conclusions: In newborn hospitalized infants, vitamin D-3 supplementation of 400 IU/day increased mean 25(OH)D levels from 17 ng/mL at birth to 23.1 ng/mL at discharge. Lower 25(OH)D levels were correlated with hypocalcemia during the first week of life, and elevated parathyroid hormone levels at discharge.
AB - Background: Evidence suggests that adequate vitamin D status in infancy plays a role in improving bone health and preventing disease, including type 1 diabetes, infections, and asthma. The objective of this study was to provide newborn hospitalized infants with American Academy of Pediatrics recommendations of 400 IU/day vitamin D-3 and measure the effect on serum 25(OH)D levels. Design: This trial was conducted August 2009 to June 2010. Infants were randomized to a control were measured from cord blood, every 7 days, and at discharge. Intact parathyroid hormone was measured at discharge. Participants/setting: Fifty-two infants <32 weeks gestational age who received formula feedings during their neonatal intensive care unit hospitalization. Statistical analysis: Patient characteristics for each treatment group were summarized using descriptive statistics. The Mann-Whitney test was used to compare continuous variables, and categorical variables were compared using the χ 2 test or Fisher's exact test. The Pearson correlation coefficient was used to look at associations between continuous variables. Results: The mean cord blood level for all participants was 17.6±7.0 ng/mL. White infants had significantly higher 25(OH)D levels than non-white infants (P=0.0003). The mean 25(OH)D level at discharge of the supplemented group was 23.1±7.0 ng/mL (57.66±17.47 nmol/L), the mean 25(OH)D level of the unsupplemented group was 17.8±4.7 ng/mL (44.43±11.3 nmol/L), (P=0.007). Serum 25(OH)D showed a positive correlation with serum calcium in the first week of life (r=0.44, P=0.003) and negative correlation with parathyroid hormone levels at discharge (r=-0.35, P=0.02). Conclusions: In newborn hospitalized infants, vitamin D-3 supplementation of 400 IU/day increased mean 25(OH)D levels from 17 ng/mL at birth to 23.1 ng/mL at discharge. Lower 25(OH)D levels were correlated with hypocalcemia during the first week of life, and elevated parathyroid hormone levels at discharge.
UR - http://www.scopus.com/inward/record.url?scp=82455209522&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=82455209522&partnerID=8YFLogxK
U2 - 10.1016/j.jada.2011.09.010
DO - 10.1016/j.jada.2011.09.010
M3 - Article
C2 - 22117659
AN - SCOPUS:82455209522
SN - 0002-8223
VL - 111
SP - 1836
EP - 1843
JO - Journal of the American Dietetic Association
JF - Journal of the American Dietetic Association
IS - 12
ER -